Optidel in collaboration with Johnson & Johnson Foundation invites you for a live webinar series on: Implementing injection-free DR-TB Regimen in the era of COVID-19: Leveraging on Kenya, Nigeria and South Africa experiences and lessons learned.
Register on: https://bit.ly/3bns8Yb
Dr Babatunde Sanni resumed duties as the the new CEO of Optidel Global LLC, USA.
He brings with him a wealth of experience in Public Health, outstanding networking and partnership prowess, and an eye for technical quality.
He has about two decades of experience in tackling public health challenges globally gained at sub-national, national and international levels as a direct staff or leading consultancy services in reputable International NGOs, Multilateral (WHO and other UN Agencies), Bilateral organizations, and Philanthropies in Africa and the United States.
He will work with the team from Optidel South Africa, Nigeria, and Kenya to move the organization forward.
Welcome Dr Babatunde Sanni!
In order to tackle the new challenges facing Global Health and to improve efficiency, effectiveness, and quality of our services, Optidel rebranded and looks at the future with a bolder outlook.
Our new brand signifies the ‘determination and passion’. We are passionately determined to alleviate the public health challenges facing the people no matter who or where they are.
We welcome new partners.